Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Multiple Sclerosis Therapeutics
... at a CAGR of 2.9% over the analysis period 2024-2030. Large-molecule Drugs, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$23.2 Billion by the end of ... Read More
-
HIV-Associated Lipodystrophy
... CAGR of 2.2% over the analysis period 2024-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 1.6% CAGR and reach US$119.2 Million by the end of the analysis ... Read More
-
Hepatoblastoma Treatment
... CAGR of 6.4% over the analysis period 2024-2030. Alkylating Agent, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$186.2 Million by the end of the analysis ... Read More
-
Healthcare Equipment Leasing
... at a CAGR of 6.3% over the analysis period 2024-2030. Medical Imaging Equipment, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$25.8 Billion by the end ... Read More
-
Hepatitis B and C Diagnostics
... Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$6.3 Billion by ... Read More
-
Homozygous Familial Hypercholesterolemia
... at a CAGR of 2.5% over the analysis period 2024-2030. Statins, one of the segments analyzed in the report, is expected to record a 1.9% CAGR and reach US$36.2 Million by the end of the ... Read More
-
Psychologists (UK) - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Psychologists (UK) report will tell you the companies that have a declining financial ... Read More
-
GLP-1: How to turn a threat into an opportunity
... ‘disruptive’ change, the narrative goes, because GLP-1a users are cutting their food spending in some categories (while increasing it in others). GLP-1a is a bigger opportunity than threat, and one that is within the capabilities ... Read More
-
Global MHC-Peptide Tetramer Market Insights, Forecast to 2031
... Tetramer is estimated to increase from 63.45 million USD in 2024 to reach 116.42 million USD by 2031, at a CAGR of 9.80% during the forecast period of 2025 through 2031. Europe market for MHC-Peptide ... Read More
-
Mental Health & Substance Abuse Services
... and Corewell Health (all based in the US), along with the Centre for Addiction and Mental Health (Canada) and the Crossroads Centre Antigua. COMPETITIVE LANDSCAPE Demand for mental health and substance abuse services is driven ... Read More
-
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by ... Read More
-
Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030
... is experiencing consistent growth due to several factors. As the global population ages, the prevalence of conditions like diabetes is rising, leading to an increased demand for advanced insulin delivery devices. Additionally, government support and ... Read More
-
Global Thymus Cancer Market - 2025-2033
... Billion by 2033, growing at a CAGR of 5.0% during the forecast period 2025-2033. Thymus Cancer Market Overview Thymus cancer is a rare malignancy that arises from the epithelial cells of the thymus gland and ... Read More
-
Denmark Data Center Market - Investment Analysis & Growth Opportunities 2025-2030
... boost their productivity and enhance operational efficiency. The Danish National Strategy for Artificial Intelligence aims to develop artificial intelligence services in the country by strengthening its ethical framework to drive business growth in Denmark. Denmark ... Read More
-
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the ... Read More
-
Respiratory Care Market, By Product Type (Nebulizers, Oxygen Concentrators , Polysomnography Devices, Positive airway pressure devices, Respiratory Consumables , and Others), By Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Pneumonia, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... is witnessing a phase of robust growth due to the increasing prevalence of respiratory diseases globally. Rising air pollution levels, growing geriatric population, and the high number of smokers are some of the key factors ... Read More
-
Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets
... July 2023. Several DMTs are in late-stage (phase 2 and above) clinical trials. If approved, they can expand the AD DMTs market significantly. BCC Research estimates market data for 2024 (the base year) and forecasts ... Read More
-
Global Leuprolide Acetate Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
The 2026-2031 World Outlook for Migraine Drugs
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Neglected Tropical Disease Treatments
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for NDDS in Cancer Therapies
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Needle-Free Diabetes Management
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Non-Hematological Cancer Treatments
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Musculoskeletal Diseases
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Novel Drug Delivery Systems in Cancer Therapies
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
Research Assistance
